Keywords: Computed Tomography, Emission Computed, Radiotherapy, Antineoplastic Agent, Fluorodeoxyglucose F 18, Breast Cancer, Cancer Radiotherapy, Cancer Relapse, Cancer Staging, Colorectal Cancer, Computer Assisted Emission Tomography, Diagnostic Accuracy, Disease Course, Esophagus Carcinoma, Gynecologic Cancer, Head And Neck Cancer, Human, Larynx Cancer, Lung Cancer, Lung Metastasis, Lung Non Small Cell Cancer, Lymphoma, Methodology, Nonhodgkin Lymphoma, Patient Selection, Radiation Dose, Radiation Sickness, Review, Seminoma, Squamous Cell Carcinoma, Stomach Carcinoma, Treatment Planning, Tumor Volume, Physician, S Practice Patterns, Positron-Emission Tomography, Practice Guidelines, Radiotherapy Planning, Computer-Assisted, Subtraction Technique, X-Ray Computed, Radioisotope, Cobalt, Cancer Surgery, Cobalt Therapy, Larynx Carcinoma, Article, Glottis, Larynx Tumor, Lymph Node Metastasis, Postoperative Care, Cobalt Radioisotopes, English Abstract, Laryngeal Neoplasms, Lymphatic Metastasis, Radiotherapy Dosage, Cobalt Radioisotopes Therapeutic Use, Laryngeal Neoplasms Radiotherapy, Postoperative Care Methods,
Affiliations: Center of Molecular Bioimaging, University of Milano-Bicocca, Milan, Italy
Institute of Molecular Bioimaging and Physiology (IBFM), CNR, Milan, Italy
Department of Nuclear Medicine, H. S. Gerardo, Via Pergolesi 33, 20052 Monza, Italy
Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy
Div. Radioter., Ist. Studio Cura Tum., 80131 Napoli, Italy
References: Giraud, P., De Rycke, Y., Dubray, B., Helfre, S., Voican, D., Guo, L., Conformal radiotherapy (CRT) planning for lung cancer: Analysis of intrathoracic organ motion during extreme phases of breathing (2001) Int J Radiat Oncol Biol Phys, 51, pp. 1081-109
Schoder, H., Yeung, H.W., Gonen, M., Kraus, D., Larson, S.M., Head and neck cancer: Clinical usefulness and accuracy of PET/CT image fusion (2004) Radiology, 231, pp. 65-72
Elshaikh, M., Ljungman, M., Ten Haken, R., Lichter, A.S., Advances in radiation oncology (2006) Annu Rev Med, 57, pp. 19-31
Mackie, T.R., Kapatoes, J., Ruchala, K., Lu, W., Wu, C., Olivera, G., Image guidance for precise conformal radiotherapy (2003) Int J Radiat Oncol Biol Phys, 56, pp. 89-105
Wechalekar, K., Sharma, B., Cook, G., PET/CT in oncology: A major advance (2005) Clin Radiol, 60, pp. 1143-1155
Lardinois, D., Weder, W., Hany, T.F., Kamel, E.M., Korom, S., Seifert, B., Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography (2003) N Engl J Med, 348, pp. 2500-2507
Pozo-Rodriguez, F., Martin de Nicolas, J.L., Sanchez-Nistal, M.A., Maldonado, A., Garcia de Barajas, S., Calero-Garcia, R., Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer (2005) J Clin Oncol, 23, pp. 8348-8356
Hellwig, D., Ukena, D., Paulsen, F., Bamberg, M., Kirsch, C.M., Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000 (2001) Pneumologie, 55, pp. 367-377
Pieterman, R.M., van Putten, J.W., Meuzelaar, J.J., Mooyaart, E.L., Vaalburg, W., Koeter, G.H., Preoperative staging of non-small-cell lung cancer with positron-emission tomography (2000) N Engl J Med, 343, pp. 254-261
Bury, T., Dowlati, A., Paulus, P., Corhay, J.L., Hustinx, R., Ghaye, B., Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer (1997) Eur Respir J, 10, pp. 2529-2534
Gallowitsch, H.J., Kresnik, E., Gasser, J., Kumnig, G., Igerc, I., Mikosch, P., F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: A comparison to conventional imaging (2003) Invest Radiol, 38, pp. 250-256
Arulampalam, T.H., Francis, D.L., Visvikis, D., Taylor, I., Ell, F.J., FDG-PET for the pre-operative evaluation of colorectal liver metastases (2004) Eur J Surg Oncol, 30, pp. 286-291
Cohade, C., Osman, M., Leal, J., Wahl, R.L., Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma (2003) J Nucl Med, 44, pp. 1797-1803
Selzner, M., Hany, T.F., Wildbrett, P., McCormack, L., Kadry, Z., Clavien, P.A., Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? (2004) Ann Surg, 240, pp. 1027-1034. , discussion 35-6
Frank, S.J., Chao, K.S., Schwartz, D.L., Weber, R.S., Apisarnthanarax, S., Macapinlac, H.A., Technology insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning (2005) Nat Clin Pract Oncol, 2, pp. 526-533
Menda, Y., Graham, M.M., Update on 18F-fluorodeoxy-glucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers (2005) Semin Nucl Med, 35, pp. 214-219
Ha, P.K., Hdeib, A., Goldenberg, D., Jacene, H., Patel, P., Koch, W., The role of positron emission tomography and computed tomography fusion in the management of early-stage and advanced-stage primary head and neck squamous cell carcinoma (2006) Arch Otolaryngol Head Neck Surg, 132, pp. 12-16
ICRU Report50, prescribing, recording, and reporting photon beam therapy (1993), Bethesda MD: International Commission on Radiation Units and Measurement (ICRU)van Herk, M., Errors and margins in radiotherapy (2004) Semin Radiat Oncol, 14, pp. 52-64
Ling, C.C., Li, X.A., Over the next decade the success of radiation treatment planning will be judged by the immediate biological response of tumor cells rather than by surrogate measures such as dose maximization and uniformity (2005) Med Phys, 32, pp. 2189-2192
Ciernik, I.F., Dizendorf, E., Baumert, B.G., Reiner, B., Burger, C., Davis, J.B., Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): A feasibility study (2003) Int J Radiat Oncol Biol Phys, 57, pp. 853-863
Solberg, T.D., Agazaryan, N., Goss, B.W., Dahlbom, M., Lee, S.P., A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy (2004) J Neurosurg, 101 (SUPPL. 3), pp. 381-389
Chao, K.S., Bosch, W.R., Mutic, S., Lewis, J.S., Dehdashti, F., Mintun, M.A., A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy (2001) Int J Radiat Oncol Biol Phys, 49, pp. 1171-1182
Lucignani, G., Jereczek-Fossa, B.A., Orecchia, R., The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control (2004) Eur J Nucl Med Mol Imaging, 31, pp. 1059-1063
Grosu, A.L., Piert, M., Weber, W.A., Jeremic, B., Picchio, M., Schratzenstaller, U., Positron emission tomography for radiation treatment planning (2005) Strahlenther Onkol, 181, pp. 483-499
Mac Manus, M.P., Hicks, R.J., Ball, D.L., Kalff, V., Matthews, J.P., Salminen, E., F-18 fluorodeoxyglucose positron emission tomography staging in radical radiotherapy candidates with nonsmall cell lung carcinoma: Powerful correlation with survival and high impact on treatment (2001) Cancer, 92, pp. 886-895
Nestle, U., Walter, K., Schmidt, S., Licht, N., Nieder, C., Motaref, B., 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis (1999) Int J Radiat Oncol Biol Phys, 44, pp. 593-597
Keall, P.J., Joshi, S., Vedam, S.S., Siebers, J.V., Kini, V.R., Mohan, R., Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking (2005) Med Phys, 32, pp. 942-951
Shimizu, S., Shirato, H., Ogura, S., Akita-Dosaka, H., Kitamura, K., Nishioka, T., Detection of lung tumor movement in real-time tumor-tracking radiotherapy (2001) Int J Radiat Oncol Biol Phys, 51, pp. 304-310
Remouchamps, V.M., Vicini, F.A., Sharpe, M.B., Kestin, L.L., Martinez, A.A., Wong, J.W., Significant reductions in heart and lung doses using deep inspiration breath hold with active breathing control and intensity-modulated radiation therapy for patients treated with locoregional breast irradiation (2003) Int J Radiat Oncol Biol Phys, 55, pp. 392-406
Wiedmann, E., Baican, B., Hertel, A., Baum, R.P., Chow, K.U., Knupp, B., Positron emission tomography (PET) for staging and evaluation of response to treatment in patients with Hodgkin's disease (1999) Leuk Lymphoma, 34, pp. 545-551
Jerusalem, G., Warland, V., Najjar, F., Paulus, P., Fassotte, M.F., Fillet, G., Whole-body 18F-FDG PET for the evaluation of patients with Hodgkin's disease and non-Hodgkin's lymphoma (1999) Nucl Med Commun, 20, pp. 13-20
Jerusalem, G., Hustinx, R., Beguin, Y., Fillet, G., PET scan imaging in oncology (2003) Eur J Cancer, 39, pp. 1525-1534
Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P., Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging (1999) Blood, 94, pp. 429-433
Weihrauch, M.R., Re, D., Scheidhauer, K., Ansen, S., Dietlein, M., Bischoff, S., Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease (2001) Blood, 98, pp. 2930-2934
Ganjoo, K.N., Chan, R.J., Sharma, M., Einhorn, L.H., Positron emission tomography scans in the evaluation of postchemotherapy residual masses in patients with seminoma (1999) J Clin Oncol, 17, pp. 3457-3460
Becherer, A., De Santis, M., Karanikas, G., Szabo, M., Bokemeyer, C., Dohmen, B.M., FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals (2005) Eur J Radiol, 54, pp. 284-288
Rosenzweig, K.E., Fox, J.L., Giraud, P., Response to radiation (2004) Semin Radiat Oncol, 14, pp. 322-325
Rusch, V.W., High-resolution computed tomography in clinical T1 N0 M0 adenocarcinoma of the lung (2002) J Thorac Cardiovasc Surg, 124, pp. 221-222
Weber, W.A., PET for response assessment in oncology: Radiotherapy and chemotherapy (2005) Br J Radiol, 15, pp. 2651-2657
Porceddu, S.V., Jarmolowski, E., Hicks, R.J., Ware, R., Weih, L., Rischin, D., Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer (2005) Head Neck, 27, pp. 175-181
Kubota, K., Yokoyama, J., Yamaguchi, K., Ono, S., Qureshy, A., Itoh, M., FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: Comparison with MRI/CT (2004) Eur J Nucl Med Mol Imaging, 31, pp. 590-595
Spaepen, K., Stroobants, S., Dupont, P., Vandenberghe, P., Thomas, J., de Groot, T., Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma (2002) Ann Oncol, 13, pp. 1356-1363
Weber, W.A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., Positron emission tomography in non-small-cell lung cancer: Prediction of response to chemotherapy by quantitative assessment of glucose use (2003) J Clin Oncol, 21, pp. 2651-2657
Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.J., Busch, R., Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: Results of a prospective trial (2003) J Clin Oncol, 21, pp. 4604-4610
Wieder, H.A., Brucher, B.L., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment (2004) J Clin Oncol, 22, pp. 900-908
Smith, I.C., Welch, A.E., Hutcheon, A.W., Miller, I.D., Payne, S., Chilcott, F., Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy (2000) J Clin Oncol, 18, pp. 1676-1688
Dose Schwarz, J., Bader, M., Jenicke, L., Hemminger, G., Janicke, F., Avril, N., Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET (2005) J Nucl Med, 46, pp. 1144-1150
Ohtsuka, T., Nomori, H., Watanabe, K., Naruke, T., Orikasa, H., Yamazaki, K., False-positive findings on [18F]FDG-PET caused by non-neoplastic cellular elements after neoadjuvant chemoradiotherapy for non-small cell lung cancer (2005) Jpn J Clin Oncol, 35, pp. 271-273
Kubota, R., Yamada, S., Kubota, K., Ishiwata, K., Tamahashi, N., Ido, T., Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography (1992) J Nucl Med, 33, pp. 1972-1980
Nishikawa, A., Furukawa, F., Imazawa, T., Ikezaki, S., Otoshi, T., Fukushima, S., Cell proliferation in lung fibrosis-associated hyperplastic lesions (1995) Hum Exp Toxicol, 14, pp. 701-705
Erdi, Y.E., Macapinlac, H., Rosenzweig, K.E., Humm, J.L., Larson, S.M., Erdi, A.K., Use of PET to monitor the response of lung cancer to radiation treatment (2000) Eur J Nucl Med, 27, pp. 861-866
Juweid, M.E., Cheson, B.D., Positron-emission tomography and assessment of cancer therapy (2006) N Engl J Med, 354, pp. 496-507
Caldwell, C.B., Mah, K., Ung, Y.C., Danjoux, C.E., Balogh, J.M., Ganguli, S.N., Observer variation in contouring gross tumor volume in patients with poorly defined non-small-cell lung tumors on CT: The impact of 18FDG-hybrid PET fusion (2001) Int J Radiat Oncol Biol Phys, 51, pp. 923-931
Fox, J.L., Rengan, R., O'Meara, W., Yorke, E., Erdi, Y., Nehmeh, S., Does registration of PET and planning CT images decrease interobserver and intraobserver variation in delineating tumor volumes for non-small-cell lung cancer? (2005) Int J Radiat Oncol Biol Phys, 62, pp. 70-75
Castiglioni, I., Rizzo, G., Gilardi, M.C., Savi, A.R., Fazio, F., Lesion detectability and quantification in PET/CT oncological studies by Monte Carlo simulations (2005) IEEE T Nucl Sci, 52, pp. 136-142
Erdi, Y.E., Mawlawi, O., Larson, S.M., Imbriaco, M., Yeung, H., Finn, R., Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding (1997) Cancer, 80, pp. 2505-2509
Black, Q.C., Grills, I.S., Kestin, L.L., Wong, C.Y., Wong, J.W., Martinez, A.A., Defining a radiotherapy target with positron emission tomography (2004) Int J Radiat Oncol Biol Phys, 60, pp. 1272-1282
Erdi, Y.E., Rosenzweig, K., Erdi, A.K., Macapinlac, H.A., Hu, Y.C., Braban, L.E., Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) (2002) Radiother Oncol, 62, pp. 51-60
Scarfone, C., Lavely, W.C., Cmelak, A.J., Delbeke, D., Martin, W.H., Billheimer, D., Prospective feasibility trial of radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging (2004) J Nucl Med, 45, pp. 543-552
Bradley, J., Thorstad, W.L., Mutic, S., Miller, T.F., Dehdashti, F., Siegel, B.A., Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer (2004) Int J Radiat Oncol Biol Phys, 59, pp. 78-86
Mah, K., Caldwell, C.B., Ung, Y.C., Danjoux, C.E., Balogh, J.M., Ganguli, S.N., The impact of (18)FDG-PET on target and critical organs in CT-based treatment planning of patients with poorly defined non-small-cell lung carcinoma: A prospective study (2002) Int J Radiat Oncol Biol Phys, 52, pp. 339-350
Messa, C., Ceresoli, G.L., Rizzo, G., Artioli, D., Cattaneo, M., Castellone, P., Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer (2005) Q J Nucl Med Mol Imaging, 49, pp. 259-266
Paulino, A.C., Koshy, M., Howell, R., Schuster, D., Davis, L.W., Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer (2005) Int J Radiat Oncol Biol Phys, 61, pp. 1385-1392
Nestle, U., Kremp, S., Schaefer-Schuler, A., Sebastian-Welsch, C., Hellwig, D., Rube, C., Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer (2005) J Nucl Med, 46, pp. 1342-1348
Yaremko, B., Riauka, T., Robinson, D., Murray, B., McEwan, A., Roa, W., Threshold modification for tumour imaging in non-small-cell lung cancer using positron emission tomography (2005) Nucl Med Commun, 26, pp. 433-440
Daisne, J.F., Sibomana, M., Bol, A., Doumont, T., Lonneux, M., Gregoire, V., Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms (2003) Radiother Oncol, 69, pp. 247-250
Geets, X., Daisne, J.F., Gregoire, V., Hamoir, M., Lonneux, M., Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: Comparison with FDG-PET and CT (2004) Radiother Oncol, 71, pp. 267-273
Zasadny, K.R., Kison, P.V., Francis, I.R., Wahl, R.L., FDG-PET determination of metabolically active tumor volume and comparison with CT (1998) Clin Positron Imaging, 1, pp. 123-129
Paulino, A.C., Johnstone, P.A., FDG-PET in radiotherapy treatment planning: Pandora's box? (2004) Int J Radiat Oncol Biol Phys, 59, pp. 4-5
Lodge, M.A., Badawi, R.D., Gilbert, R., Dibos, P.E., Line, B.R., Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner (2006) J Nucl Med, 47, pp. 23-31
Nehmeh, S.A., Erdi, Y.E., Pan, T., Pevsner, A., Rosenzweig, K.E., Yorke, E., Four-dimensional (4D) PET/CT imaging of the thorax (2004) Med Phys, 31, pp. 3179-3186
PET/CT and radiotherapy
This article reviews the state of the art of PET/CT applications in radiotherapy, specifically its use in disease staging, patient selection, treatment planning and treatment evaluation. Diseases for which radiotherapy with radical intent is indicated will be considered, as well as those in which PET/CT may actually change the course of disease. The methodological and technological aspects of PET/CT in radiotherapy are discussed, focusing on the problem of target volume definition with CT and PET functional imaging and the problem of tumor motion with respect to imaging and dose delivery.
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(284 views) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 ViewExport to BibTeXExport to EndNote
Ntziachristos V, Cuénod CA, Fournier L, Balvay D, Pradel C, Siauve N, Clement O, Jouannot E, Lucidarme O, Vecchio SD, Salvatore M, Law B, Tung C-H, Jain RK, Fukumura D, Munn LL, Brown EB, Schellenberger E, Montet X, Weissleder R, Clerck ND, Postnov A * Tumor Imaging(350 views) Textbook Of In Vivo Imaging In Vertebrates (ISSN: 9780-4700), 2007 Jul 16; 1: 277-309. Impact Factor:1.148 ViewExport to BibTeXExport to EndNote